Extensive Morphea Following Adjuvant Radiotherapy for Breast Carcinoma-Case Report
- PMID: 39851966
- PMCID: PMC11763508
- DOI: 10.3390/curroncol32010050
Extensive Morphea Following Adjuvant Radiotherapy for Breast Carcinoma-Case Report
Abstract
Radiation-induced morphea (RIM) is a rare complication following radiotherapy (RT) for breast cancer treatment. Its distribution is usually confined to the breast having received radiotherapy. A generalized form of RIM also exists, defined as lesions extending beyond the radiotherapy site, but data on the subject are scarce in the literature. This complication remains difficult to treat, due partly to the variable extent of disease and to individual clinical response rates to the wide array of available therapies, such as topical therapy (i.e., topical tacrolimus or topical corticosteroids), phototherapy, and systemic therapy (i.e., systemic immunosuppressants). We present a case of extensive morphea post RT for breast cancer with 2 years of favorable evolution under systemic therapy.
Keywords: Koebner phenomenon; breast cancer; lichen sclerosis; oncodermatology; radiation therapy; radiation-induced morphea.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.Cochrane Database Syst Rev. 2018 Jul 9;7(7):CD011492. doi: 10.1002/14651858.CD011492.pub2. Cochrane Database Syst Rev. 2018. PMID: 29987845 Free PMC article.
-
[Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].Ann Dermatol Venereol. 2010 Jan;137(1):21-31. doi: 10.1016/j.annder.2009.12.004. Epub 2009 Dec 29. Ann Dermatol Venereol. 2010. PMID: 20110064 French.
-
A systematic overview of radiation therapy effects in breast cancer.Acta Oncol. 2003;42(5-6):532-45. doi: 10.1080/02841860310014444. Acta Oncol. 2003. PMID: 14596511
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19. Eur J Cancer. 2007. PMID: 17182241
References
-
- Röcken M., Ghoreschi K. Morphea and Lichen Sclerosus. In: Bolognia J.L., Schaffer J.V., Cerroni L., editors. Dermatology. 5th ed. Volume 1. Elsevier; Philadelphia, PA, USA: 2024. pp. 717–731.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical